← Back to Search

Ultrasound Imaging

3D Ultrasound Imaging for Breast Cancer

Phase < 1
Recruiting
Led By Shigao D Chen, Ph.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age of 18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Study Summary

This trial assesses a new 3D ultrasound imaging technique to examine axillary lymph nodes in people with breast cancer. Ultrasound uses sound waves to create images of the body.

Who is the study for?
This clinical trial is for women over the age of 18 who have breast cancer and are scheduled to undergo a biopsy of their axillary lymph nodes, which are located near the armpits. It's not open to prisoners or adults unable to consent.Check my eligibility
What is being tested?
The study is testing a new imaging technology called 3D ultrasound (3D-US) to see how well it can evaluate axillary lymph nodes in patients with breast cancer compared to standard imaging methods.See study design
What are the potential side effects?
Since this trial involves non-invasive ultrasound imaging, there are minimal side effects expected. The procedure may involve some discomfort similar to that experienced during regular ultrasounds.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Axillary lymph node (ALN) diagnosis by radiologist (benign or malignant) (Aim 2)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (3D-US)Experimental Treatment1 Intervention
Patients undergo 3D-US on study. Patients who have an ALN clip placed and undergoing neoadjuvant chemotherapy undergo imaging of the clipped node before surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound Imaging
2018
Completed Phase 4
~730

Find a Location

Who is running the clinical trial?

National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
89 Previous Clinical Trials
19,691 Total Patients Enrolled
6 Trials studying Breast Cancer
1,134 Patients Enrolled for Breast Cancer
Mayo ClinicLead Sponsor
3,216 Previous Clinical Trials
3,767,428 Total Patients Enrolled
83 Trials studying Breast Cancer
13,810 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,671 Previous Clinical Trials
40,926,709 Total Patients Enrolled
940 Trials studying Breast Cancer
1,543,360 Patients Enrolled for Breast Cancer

Media Library

3D Ultrasound (Ultrasound Imaging) Clinical Trial Eligibility Overview. Trial Name: NCT05704283 — Phase < 1
Breast Cancer Research Study Groups: Diagnostic (3D-US)
Breast Cancer Clinical Trial 2023: 3D Ultrasound Highlights & Side Effects. Trial Name: NCT05704283 — Phase < 1
3D Ultrasound (Ultrasound Imaging) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05704283 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available places left for enrolment in this experiment?

"This clinical trial, initially posted on March 1st 2023, is not presently recruiting participants as indicated in the data hosted by clinicaltrials.gov. Nevertheless, there are 2238 other medical studies actively accepting patients right now."

Answered by AI
~26 spots leftby Apr 2025